rs201455322

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_000033.4(ABCD1):​c.707G>A​(p.Arg236His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000651 in 1,209,571 control chromosomes in the GnomAD database, including 4 homozygotes. There are 251 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R236C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0012 ( 2 hom., 46 hem., cov: 26)
Exomes 𝑓: 0.00060 ( 2 hom. 205 hem. )

Consequence

ABCD1
NM_000033.4 missense

Scores

6
5
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: 3.27

Publications

1 publications found
Variant links:
Genes affected
ABCD1 (HGNC:61): (ATP binding cassette subfamily D member 1) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. This peroxisomal membrane protein is likely involved in the peroxisomal transport or catabolism of very long chain fatty acids. Defects in this gene have been identified as the underlying cause of adrenoleukodystrophy, an X-chromosome recessively inherited demyelinating disorder of the nervous system. [provided by RefSeq, Jul 2008]
ABCD1 Gene-Disease associations (from GenCC):
  • adrenoleukodystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • X-linked cerebral adrenoleukodystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet
  • hereditary spastic paraplegia
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • adrenomyeloneuropathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 4 benign, 12 uncertain in NM_000033.4
BP4
Computational evidence support a benign effect (MetaRNN=0.018246949).
BP6
Variant X-153725973-G-A is Benign according to our data. Variant chrX-153725973-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 193034. Variant chrX-153725973-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 193034. Variant chrX-153725973-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 193034. Variant chrX-153725973-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 193034. Variant chrX-153725973-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 193034. Variant chrX-153725973-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 193034. Variant chrX-153725973-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 193034. Variant chrX-153725973-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 193034.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00115 (131/113821) while in subpopulation AMR AF = 0.00486 (53/10900). AF 95% confidence interval is 0.00382. There are 2 homozygotes in GnomAd4. There are 46 alleles in the male GnomAd4 subpopulation. Median coverage is 26. This position passed quality control check.
BS2
High AC in GnomAd4 at 131 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCD1NM_000033.4 linkc.707G>A p.Arg236His missense_variant Exon 1 of 10 ENST00000218104.6 NP_000024.2 P33897
ABCD1NM_001440747.1 linkc.707G>A p.Arg236His missense_variant Exon 1 of 11 NP_001427676.1
ABCD1XM_047441917.1 linkc.707G>A p.Arg236His missense_variant Exon 1 of 8 XP_047297873.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCD1ENST00000218104.6 linkc.707G>A p.Arg236His missense_variant Exon 1 of 10 1 NM_000033.4 ENSP00000218104.3 P33897
ABCD1ENST00000370129.4 linkc.152G>A p.Arg51His missense_variant Exon 1 of 2 2 ENSP00000359147.3 A6NEP8

Frequencies

GnomAD3 genomes
AF:
0.00115
AC:
131
AN:
113821
Hom.:
2
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.000127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00486
Gnomad ASJ
AF:
0.0229
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000348
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000187
Gnomad OTH
AF:
0.00131
GnomAD2 exomes
AF:
0.00142
AC:
254
AN:
178848
AF XY:
0.00125
show subpopulations
Gnomad AFR exome
AF:
0.0000783
Gnomad AMR exome
AF:
0.00146
Gnomad ASJ exome
AF:
0.0254
Gnomad EAS exome
AF:
0.000147
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000163
Gnomad OTH exome
AF:
0.00247
GnomAD4 exome
AF:
0.000600
AC:
657
AN:
1095750
Hom.:
2
Cov.:
32
AF XY:
0.000566
AC XY:
205
AN XY:
362198
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26395
American (AMR)
AF:
0.00119
AC:
42
AN:
35188
Ashkenazi Jewish (ASJ)
AF:
0.0224
AC:
433
AN:
19350
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30195
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54123
European-Finnish (FIN)
AF:
0.0000260
AC:
1
AN:
38392
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4136
European-Non Finnish (NFE)
AF:
0.000115
AC:
97
AN:
841906
Other (OTH)
AF:
0.00171
AC:
79
AN:
46065
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
33
67
100
134
167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00115
AC:
131
AN:
113821
Hom.:
2
Cov.:
26
AF XY:
0.00128
AC XY:
46
AN XY:
35945
show subpopulations
African (AFR)
AF:
0.000127
AC:
4
AN:
31419
American (AMR)
AF:
0.00486
AC:
53
AN:
10900
Ashkenazi Jewish (ASJ)
AF:
0.0229
AC:
61
AN:
2666
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3614
South Asian (SAS)
AF:
0.000348
AC:
1
AN:
2873
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6421
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.000187
AC:
10
AN:
53468
Other (OTH)
AF:
0.00131
AC:
2
AN:
1531
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00151
Hom.:
56
Bravo
AF:
0.00133
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00119
AC:
8
ExAC
AF:
0.00105
AC:
127
EpiCase
AF:
0.000491
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Adrenoleukodystrophy Uncertain:1Benign:5
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 16, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:flagged submission
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Uncertain:1Benign:2
Sep 16, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 11, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 12175782, 23430809, 33151932) -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ABCD1: BS1, BS2 -

Inborn genetic diseases Benign:1
Oct 04, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Uncertain
0.090
D
BayesDel_noAF
Pathogenic
0.33
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.91
D;D
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.81
T;T
M_CAP
Pathogenic
0.72
D
MetaRNN
Benign
0.018
T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
2.0
M;.
PhyloP100
3.3
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.0
D;D
REVEL
Pathogenic
0.76
Sift
Uncertain
0.025
D;D
Sift4G
Benign
0.073
T;T
Polyphen
1.0
D;.
Vest4
0.44
MVP
1.0
MPC
1.7
ClinPred
0.064
T
GERP RS
5.4
PromoterAI
0.019
Neutral
Varity_R
0.20
gMVP
0.56
Mutation Taster
=69/31
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201455322; hg19: chrX-152991428; API